Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair. (Q39220127)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair. |
scientific article |
Statements
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair (English)
A Gutiérrez-González
J Bargiela-Iparraguirre
G Dominguez
P García Alfonso
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference